Delivery Order SPE2DB22D3501-SPE2DB25FVW72
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Journavx 50 mg tablets (30-count units) valued at $1,561.55. This non-set-aside, competitively awarded contract employs firm fixed pricing and carries an ultimate completion date of August 27, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,136.12 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Journavx 50 mg tablets (30-count packaging). The contract is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for supply of Journavx 50 mg tablets (30-count packaging) valued at $3,048.36. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made...
- This delivery order, valued at $5,998.20, was awarded to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Journavx 50 mg tablets (30-count units) to support federal medical procurement needs. The contract represents a non-competitive, firm fixed-price delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX and running through December...
- The Defense Logistics Agency awarded a $2,111.64 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Journavx 50 mg tablets (100-count unit dose packaging). This firm fixed-price contract, which is not set-aside and is competitively awarded, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,269.06 to AmerisourceBergen Drug Corp for JOURNAVX 50 MG tablets (30-count supply), with an ultimate completion date of September 17, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value through December 2026. AmerisourceBergen Drug Corp,...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide JOURNAVX 50 MG TABLET 30S. The contract has a firm fixed price of $3,167.50 and a completion date of June 17, 2025. It is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December...
- This federal contract award, valued at $1,572.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication "JOURNAVX 50 MG TABLET 30S" and has an ultimate completion date of March 27, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4568296985 ! JOURNAVX 50 MG TABLET 30S, with an ultimate completion date of May 20, 2025 and a ceiling value of $5,022.21. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $14,309.24 delivery order to AmerisourceBergen Drug Corp for 60-tablet bottles of Jaypirca 100 mg tablets, with completion targeted for July 11, 2025. This non-set-aside, competitively awarded contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement. The order will be fulfilled from the company's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FVW72Delivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Journavx 50 mg tablets (30-count units) with a ceiling value of $1,421.66. This firm fixed-price delivery order, which became effective on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded without set-aside restrictions, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. Performance of this delivery order is located at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor supporting federal medical procurement needs across military and veteran healthcare systems. The company holds a substantial IDC valued at $999,999,999.00 running through December 2026, which functions as a global pharmaceutical support vehicle enabling the supply of a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Journavx represents a component of AmerisourceBergen's extensive portfolio of federal pharmaceutical contracts with DLA, positioning the company as a critical vendor for military healthcare program support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 5/30/25 |